TRU
TRUSCREEN FPO NZX [TRU]
Healthcare · ASX Small Cap
$0.0130 +8.3%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical51
Catalyst50
Sentiment50
Fundamental28
Momentum40
Risk Gate35
Get alerts when TRU's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic just turned bullish from a low level — early reversal sign
- Volume surging at 2.3x normal while price falls — heavy selling pressure
- Low cash runway (3 quarters) - dilution risk
- Moderate P/S ratio (5.3x)
- Revenue in sharp decline (-20%)
- Near 52-week low (6% of range)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (2.75%/day)
- Penny stock risk ($0.013)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-136%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 48% over the past year
- Revenue declining at -20% — the top line is shrinking
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about TRU
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Study Confirms Superiority of TRU and hr-HPV Co-testing
NONE Change of Director's Interest Notice
NONE Results Guidance FY2026
Recent ASX Announcements
| 2026-03-08 | Study Confirms Superiority of TRU and hr-HPV Co-testing |
| 2026-02-27 | Change of Director's Interest Notice |
| 2026-02-25 | Results Guidance FY2026 PRICE SENSITIVE |
| 2026-02-23 | Management Update |
| 2026-02-10 | TruScreen Validated as Superior Primary Screening Tool PRICE SENSITIVE |
Key Metrics
$9.7M
Market Cap
313K
Avg Volume
2.3x
Vol Ratio
$0.01 — $0.03
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-90.8%
ROE
-135.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 80% |
| L | Leader vs Laggard | laggard | RS: -3 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #91 of 117 · Sector avg: 46
View all Healthcare signals →Track TRU and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required